BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Pacira BioSciences Appoints Samit Hirawat, M.D., to Board of Directors

  January 29, 2026

   · 

  7 min read
• Press Releases

  Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies

  January 29, 2026

   · 

  3 min read
• Press Releases

  Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

  January 29, 2026

   · 

  8 min read
• Press Releases

  Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine

  January 29, 2026

   · 

  18 min read
• Press Releases

  Boehringer Ingelheim convenes “Detect the SOS” Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks

  January 29, 2026

   · 

  7 min read
• Press Releases

  GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF

  January 29, 2026

   · 

  8 min read
• Press Releases

  CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson’s Disease

  January 29, 2026

   · 

  5 min read
• Press Releases

  PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026

  January 29, 2026

   · 

  3 min read
• Press Releases

  Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine

  January 29, 2026

   · 

  3 min read
• Press Releases

  PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI

  January 29, 2026

   · 

  7 min read